IQVIA Holdings Inc (IQVIA) is a provider of clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries. The company leverages its IQVIA Connected Intelligence platform to deliver insights and services based on high-quality health data, AI, advanced analytics, and technology. The company’s portfolio includes a wide range of services and solutions. These encompass analytics-driven clinical development, real-world solutions, and a growing set of proprietary clinical and commercial applications.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

IQVIA is focused on advancing its research and development capabilities through a comprehensive portfolio of solutions that include project management, clinical monitoring, clinical trial support services, laboratory services, strategic planning and design, and patient and site-centric solutions. The company leverages its data science capabilities to improve decisions and performance in clinical trials, offering consultation services for protocol planning, biomarker consultation, regulatory affairs, and personalized medicine. IQVIA's R&D initiatives are supported by its global clinical development capabilities, expertise in biomarkers and genomics, and a global laboratory network, positioning the company to manage the complexities of international drug development. The R&D unit of IQVIA is primarily managed through its Research & Development Solutions segment. This unit is responsible for providing outsourced clinical research and clinical trial services, primarily serving biopharmaceutical clients. The unit's role includes the efficient conduct and coordination of multi-site clinical trials, protocol design, feasibility and operational planning, site start-up, patient recruitment, and clinical site monitoring. Additionally, the unit offers laboratory services and strategic planning and design consultation to support clinical trials. As of December 2025, IQVIA had 304 offices and laboratories located in 87 countries. Nearly all of the top 100 global pharmaceutical and biotechnology companies, measured by revenues, are clients of IQVIA